Cell Biosciences plans to gain ground in the protein-based drugs market by acquiring Convergent Bioscience at the end of October for a cash sum of $12m (€8.6m.)
GlaxoSmithKline (GSK) has entered into two unrelated development deals by signing license agreements for Delphi Genetics’ StabyExpress for its vaccine production operations and OncoMethylome Sciences’ DNA methylation specific PCR biomarkers for its cancer...
RecipharmCobra Biologics has received US and EU patent protection for an antibiotic resistance gene-free plasmid maintenance technology it claims can boost biomanufacturing yields.
DNA sequencing specialist Genewiz has added gene synthesis to its service portfolio, providing researchers with a time- and cost-saving alternative to techniques such as molecular cloning and protein engineering.
Laureate Pharma and Selexis SA have entered into a joint-marketing relationship, drawing on their respective strengths in contract manufacturing and cell line development to shorten timelines.
Lonza says that to the Indian market was a key motivation for its acquisition of Simbiosys Biowares India preclinical cell and molecular biology assets.
GATC Biotech has expanded its human genome sequencing services and, having performed a pilot study, is “amazed” by the potential the techniques have for cancer research and diagnostics.
Sigma-Aldrich is using a novel methodology to create rats with targeted gene deletion in as little as four months, which it believes could eliminate years of research and improve drug development.
India-based CRO Vimta Labs is aiming to lower the cost of diagnostic services by developing new panels using MassTag PCR technology licensed from Columbia University, New York.
Researchers have developed a drug delivery vehicle using liposomes and aptamers that targets specific cancer cells and can be switched off to stop adverse reactions.
At BIO 2009 Cobra Biomanufacturing explained to Outsourcing-Pharma its maxXpress service, its thoughts on expanding to commercial scale and the recent deal with KAHR Medical.
Pfizer has gained a license for the use of certain ZFP Nuclease (ZFNs) reagents from Sangamo BioSciences, which it will use to modify Chinese Hamster Ovary (CHO) cell lines.
Tepnel Life Sciences has expanded its pharmaceutical services offering by becoming the UK’s first genetic analysis services provider to use Illumina’s next-generation iScan system.
The MicroSEQ detection platform, developed by Applied Biosystems, looks set to revolutionise the detection of bacterial Mycoplasma in industrial scale biopharmaceutical manufacturing.
Dutch sample and assay technology expert Qiagen has continued its march into the detection system market with the acquisition of Biotage’s Biosystems business.
BioTrove has launched a series of assay panels that enable researchers to skip the laborious initial steps of gene selection and assay optimisation and start studying disease pathways straightaway.
Phylogeny has launched the first microRNA (miRNA) in situ hybridisation detection service to help scientists delve deeper into the mechanisms controlling key biological processes.
UK-based deltaDOT has launched a new assay that dramatically reduces the time needed to quantify the number of baculovirus expression vectors present in a sample.
Agilent and Millipore have formed a collaboration to develop fully validated chromatin immunoprecipitation (ChIP) microarray kits that will improve productivity and streamline epigenetic analysis.
Applied Biosystems (ABI) has developed a sequencing-based tool for gene expression analysis that can detect even minute amounts of previously unknown RNA transcripts.
Caliper Life Sciences has launched two new microfluidic-based electrophoresis instruments designed to address the separation needs of proteomic and genomic researchers.
Scientists have completed the most comprehensive mammalian transcriptome analysis to date and believe the results should further our understanding of disease pathways.
Bio-Rad has launched a new web-based search tool to give researchers easier access to its validated siLentMer gene silencing product line, which offers up to twice the silencing longevity.
Sangamo Biosciences and Sigma-Aldrich have licensed their zinc
finger nuclease (ZFN) technology to Roche to enable the pharma
giant to develop cell lines and transgenic animals.
Sigma-Aldrich has introduced a new high-throughput (HT) plasmid DNA
purification kit for transfection applications in pharmaceutical
and biotechnology research.
Germany's Bayer hopes that its pilot-scale production facility in
Halle, Saxony-Anhalt will help establish its tobacco plant-based
expression system as leader of the lucrative protein manufacturing
sector.
Beckman Coulter and Orchid Cellmark have filed a lawsuit against
Sequenom in another patent infringement case that alleges Sequenom
is guilty of violating patents belonging to Orchid and licensed to
Beckman.
Genetically modified (GM) maize is the most effective
biomanufacturing platform for the production of monoclonal
antibodies to combat HIV, according to research published in
PNAS.
An artificial self-assembling virus capable of serving as a drug
delivery system has been created by researchers in Korea, according
to a publication in Angewandte Chemie.
Germany-based Gene Bridges has licensed its Red/ET Recombineering
technology to Novozymes for genetically engineering recombinant
micro-organisms for use in industrial applications.
Invitrogen has immersed itself in yet more legal wrangling after
the life sciences firm filed a patent lawsuit against GE Healthcare
alleging 'wilful' infringement of its intellectual property.
A rapid microbial detection kit presented as the only genetic-based
test on the market to quantify yeast and mould has been launched by
Switzerland's Lonza.
Denmark's Novozymes has signed an exclusive worldwide licensing
agreement with CSL Behring for albufuse, a proprietary albumin
fusion technology that can extend the circulatory half-life of
therapeutic proteins through genetic...
Genomic services firm Expression Analysis has purchased the
first-ever commercially-available technology to allow the
sequencing of a single molecule of DNA, without amplification.
Scientists have successfully created the first artificial
transposon - a piece of DNA which randomly "jump" around the
genome, cutting and pasting itself throughout the strands of DNA.
Applied Biosystems has sequenced a human genome for just $60,000 in
a project that significantly undercuts the $100,000 milestone
achieved by the industry and setting the scene for a price war
between DNA sequencing tool specialists.
Bayer Healthcare is to deploy a new technique, developed by
Millipore, for genetically engineering cells to produce
pharmaceutically useful proteins that could both increase the yield
and accelerate drug production.
Denmark's Novozymes has renewed and extended its collaboration with
UK-based biotech Upperton Limited on a drug delivery system that
exploits the natural binding properties of recombinant protein
nanoparticles to improve compound...
After several years, Invitrogen and Agilent have at last settled
patent infringement court cases concerning tools used in
complementary DNA synthesis, polymerase chain reaction (PCR) and
other molecular biology applications.
A new technique that analyses the structural characteristics, and
not the sequence, of DNA has revealed previously unknown areas of
the human genetic code responsible for gene expression.
